Power Law company profile

Calliditas

Biotech & Life Sciences · Stockholm, Sweden · Founded 1992 · IPO 2018 Unicorn

Pharmaceutical company developing high value products for patients with significant unmet medical needs

Valuation

$1.05B

Market cap · 2026

Revenue

$420M

Latest reported FY

EBITDA

$447M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

1 investor on Calliditas's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 1 investor entered at this stage

Industrifonden

Global footprint

Where Calliditas has talent and traffic

Workforce by country

6 countries with
team presence

🇺🇸 United States65.5%

🇸🇪 Sweden24.8%

🇫🇷 France4.1%

🇨🇭 Switzerland3.6%

🇬🇧 United Kingdom1.8%

Top 5 of 6 shown

Web traffic by country

3.4K monthly visits
across markets

🇺🇸 United States85.3%

🇮🇳 India14.7%

Top 2 markets shown

Patent intelligence

$13M patent portfolio · 10 active families

Estimated portfolio value

$13M

1.2% of market cap · 41.7× smaller than top peer ChemoCentryx ($524M)

10 active patent families

Where Calliditas innovates DrugPharmaceutical drugOrganic chemistryBudesonideGastrointestinal tract

Where Calliditas concentrates vs peers

Each axis is a top-10 topic across Calliditas and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Calliditas

An AI-synthesized read of the highest-engagement posts about Calliditas on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Calliditas on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles